Nirmatrelvir drug for Covid-19, molecular model
Nirmatrelvir drug for Covid-19, molecular model. Nirmatrelvir is an antiviral medication developed to treat Covid-19. The drug is a protease inhibitor that acts on the spike protein of the SARS-CoV-2 virus. Paxlovid, a combination drug of nirmatrelvir and the antiviral ritonavir is currently in Phase III testing. Atoms are colour-coded: carbon is black; hydrogen is white; nitrogen is blue; oxygen is red.
Size: 4500px × 4500px
Location:
Photo credit: © GREG WILLIAMS/SCIENCE PHOTO LIBRARY / Alamy / Afripics
License: Licensed
Model Released: No
Keywords: -, 3d, antiviral, artwork, background, ball, biochemical, biochemistry, chemical, chemistry, coronavirus, covid, covid-19, cut, cutout, drug, illustration, inhibitor, medication, medicinal, medicine, model, molecular, molecule, nirmatrelvir, paxlovid, pf-07321332, protease, render, rendering, ritonavir, sars--2, stick, structure, treatment, white